abstract |
The present invention provides a peptide compound Asp-Leu-Arg-Val as a therapeutic agent for preventing and / or treating cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, cardiovascular diseases and metabolic diseases. -Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn -Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH It relates to the use of. In addition, the present invention optionally comprises a peptide Asp-Leu-Arg-Val-Asp-Thr-, in combination with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and / or diluent. Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys- Preferably containing Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH Relates to pharmaceutical compositions in the form of lyophilized or liquid buffers or artificial breast milk preparations or mother milk substitutes. |